MedPath

Carbon Dioxide-laser Versus Harmonic Scalpel in the Treatment of Pelvic Pain Due to Endometriosis

Not Applicable
Completed
Conditions
Endometriosis
Registration Number
NCT02282943
Lead Sponsor
Mr Andrew Kent
Brief Summary

The purpose of this study is to compare laser CO2 ablation/excision of Endometriosis (AFS stages 1-3) with excision of endometriosis using the Ethicon Harmonic ACE device. Pain scores at 6 months was the primary outcome, but secondary outcomes assessed pain scores at 1, 3 and 5 years as well as psychological state and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
112
Inclusion Criteria
  • Endometriosis grade I-III by revised American Fertility Society Scoring
  • Patients in whom laser treatment to the endometriosis is considered the treatment of choice.
  • Patients having consented to participated in the trial
  • Patient is 18 years old or greater
  • Patients who have no contraindications to either of the treatment modalities proposed
Exclusion Criteria
  • Patients who do not wish to participate/have not signed the informed consent form
  • Pregnancy of breast feeding
  • Patients who are unable or unwilling to discontinue hormonal treatment for 6 months
  • Patients who have received additional treatment for their endometriosis within 6 months of surgery
  • Patients with documented painful conditions of the gastrointestinal or urinary system

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Visual analogue pain score (VAS) change at 6 months compared to preoperative baseline6 months
Secondary Outcome Measures
NameTimeMethod
Quality of life survey (Endometriosis Health Profile Questionnaire)0, 3, 6 months and 1,3,5 years
Visual analogue pain score (VAS) change from baseline1,3 and 5 years
Psychological state0, 3 ,6 months and 1,3,5 years

Hospital Anxiety \& Depression Scale

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.